Article
Viral and non‐viral gene therapy using 3D (bio)printing
24 Oct 2022
Abstract excerpt
The overall success in launching discovered drugs is tightly restricted to the high rate of late-stage failures, which ultimately inhibits the distribution of medicines in markets. As a result, it is imperative that methods reliably predict the effectiveness and, more critically, the toxicity of medicine early in the drug development process before clinical trials be continuously innovated. We must stay up to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
